drugset / Trial / NCT00832364
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to assess the safety and efficacy of an injectable biologic and U0279 as combination therapy compared to that of an injectable biologic alone for severe plaque-type psoriasis.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-03
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acitretin | Small molecule | 25 mg | Oral |
| Background | Etanercept | Protein / enzyme biologic | — | — |